Novo Nordisk's OpenAI Partnership & How AI is Revolutionizing Drug Development
Impossible d'ajouter des articles
Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.
Veuillez réessayer plus tard
Veuillez réessayer plus tard
Échec de l’élimination de la liste d'envies.
Veuillez réessayer plus tard
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
Novo Nordisk's OpenAI Partnership & How AI is Revolutionizing Drug Development
-
Lu par :
-
De :
À propos de ce contenu audio
Novo Nordisk teamed up with OpenAI, a partnership intended to shorten timelines and improve accuracy in drug development.
In this episode, Kelsey Sung interviews Cliff Saran of Computer Weekly about Novo Nordisk's groundbreaking partnership with OpenAI. They explore how AI is transforming drug development, reducing timelines, and addressing challenges in healthcare innovation. This collaboration also hints at a future where AI might reduce the need for animal testing, a controversial but promising step forward in ethical research.
Featuring: Cliff Saran, Computer Weekly
Read more: Novo Nordisk partners with OpenAI to AI-power drug development
Aucun commentaire pour le moment